Skip to Content, Navigation, or Footer.
The Tufts Daily
Where you read it first | Saturday, June 15, 2024

Manek Khedia

The Setonian

This Week in Science: HPV vaccine effective, new Delta strain emerges, UK approves COVID pill

The human papillomavirus (HPV) vaccine has the potential to reduce cases of cervical cancer by 87% and prevent certain cervical abnormalities by 97%, according to a British study recently published in The Lancet. Researchers examined women a decade after their HPV vaccinations and found that there was a reduction in pre-cancerous growths as well as cervical cancer. In 2006, the FDA approved the HPV vaccine, Gardasil, and since then, two other HPV vaccines have been developed and over 100 countries have incorporated the HPV vaccine into their regular inoculation schedules.

More articles »